{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T18:04:02Z","timestamp":1793124242056,"version":"4.5.0"},"reference-count":184,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,6,18]],"date-time":"2021-06-18T00:00:00Z","timestamp":1623974400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pharmacological Research"],"published-print":{"date-parts":[[2021,8]]},"DOI":"10.1016\/j.phrs.2021.105700","type":"journal-article","created":{"date-parts":[[2021,6,2]],"date-time":"2021-06-02T00:00:18Z","timestamp":1622592018000},"page":"105700","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":74,"special_numbering":"C","title":["Cytisine and cytisine derivatives. More than smoking cessation aids"],"prefix":"10.1016","volume":"170","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5358-8643","authenticated-orcid":false,"given":"Cecilia","family":"Gotti","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Clementi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.phrs.2021.105700_bib1","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/S0022-3565(25)03932-1","article-title":"The physiological action of cytisine, the active alkaloid of laburnum(cytius-laburnum)","volume":"3","author":"Dale","year":"1912","journal-title":"J. Physiol. Exp. Ther. III"},{"issue":"1\u20133","key":"10.1016\/j.phrs.2021.105700_bib2","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1016\/j.forsciint.2009.01.011","article-title":"Fatal cytisine intoxication and analysis of biological samples with LC-MS\/MS","volume":"186","author":"Musshoff","year":"2009","journal-title":"Forensic Sci. Int."},{"key":"10.1016\/j.phrs.2021.105700_bib3","first-page":"10","article-title":"Laburnum poisoning and cytisine","volume":"5","author":"Laidlaw","year":"1912","journal-title":"Proc. R. Soc. Med."},{"issue":"15","key":"10.1016\/j.phrs.2021.105700_bib4","doi-asserted-by":"crossref","first-page":"1553","DOI":"10.1001\/archinte.166.15.1553","article-title":"Cytisine for smoking cessation: a literature review and a meta-analysis","volume":"166","author":"Etter","year":"2006","journal-title":"Arch. Intern. Med."},{"issue":"3","key":"10.1016\/j.phrs.2021.105700_bib5","first-page":"1475","article-title":"Cytisine induces endoplasmic reticulum stress caused by calcium overload in HepG2 cells","volume":"39","author":"Yu","year":"2018","journal-title":"Oncol. Rep."},{"issue":"5","key":"10.1016\/j.phrs.2021.105700_bib6","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1039\/c2np00100d","article-title":"Cytisine: a natural product lead for the development of drugs acting at nicotinic acetylcholine receptors","volume":"29","author":"Perez","year":"2012","journal-title":"Nat. Prod. Rep."},{"issue":"11","key":"10.1016\/j.phrs.2021.105700_bib7","doi-asserted-by":"crossref","first-page":"1951","DOI":"10.1111\/add.14721","article-title":"Cytisine for nicotine addiction treatment: a review of pharmacology, therapeutics and an update of clinical trial evidence for smoking cessation","volume":"114","author":"Tutka","year":"2019","journal-title":"Addiction"},{"issue":"6","key":"10.1016\/j.phrs.2021.105700_bib8","first-page":"777","article-title":"Cytisine for the treatment of nicotine addiction: from a molecule to therapeutic efficacy","volume":"58","author":"Tutka","year":"2006","journal-title":"Pharmacol. Rep."},{"key":"10.1016\/j.phrs.2021.105700_bib9","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1080\/13102818.2007.10817436","article-title":"From ethomedical use to the development as a natural alternative for smoking cessation","volume":"21","author":"Tzhankova","year":"2007","journal-title":"Biotechnol. Biotechnol. Equip."},{"issue":"25","key":"10.1016\/j.phrs.2021.105700_bib10","doi-asserted-by":"crossref","first-page":"2353","DOI":"10.1056\/NEJMoa1407764","article-title":"Cytisine versus nicotine for smoking cessation","volume":"371","author":"Walker","year":"2014","journal-title":"N. Engl. J. Med."},{"issue":"37","key":"10.1016\/j.phrs.2021.105700_bib11","doi-asserted-by":"crossref","first-page":"4413","DOI":"10.2174\/1381612825666181123124733","article-title":"Cytisine \u2013 from the past to the future","volume":"24","author":"Paduszynska","year":"2018","journal-title":"Curr. Pharm. Des."},{"issue":"1","key":"10.1016\/j.phrs.2021.105700_bib12","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1152\/physrev.00015.2008","article-title":"Mammalian nicotinic acetylcholine receptors: from structure to function","volume":"89","author":"Albuquerque","year":"2009","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.phrs.2021.105700_bib13","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1146\/annurev.pharmtox.47.120505.105214","article-title":"Nicotinic acetylcholine receptors and nicotinic cholinergic mechanisms of the central nervous system","volume":"47","author":"Dani","year":"2007","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"issue":"6","key":"10.1016\/j.phrs.2021.105700_bib14","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/j.pneurobio.2004.09.006","article-title":"Neuronal nicotinic receptors: from structure to pathology","volume":"74","author":"Gotti","year":"2004","journal-title":"Prog. Neurobiol."},{"issue":"9","key":"10.1016\/j.phrs.2021.105700_bib15","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1016\/j.tips.2006.07.004","article-title":"Brain nicotinic acetylcholine receptors: native subtypes and their relevance","volume":"27","author":"Gotti","year":"2006","journal-title":"Trends Pharmacol. Sci."},{"issue":"Pt. B","key":"10.1016\/j.phrs.2021.105700_bib16","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1016\/j.neuropharm.2014.11.003","article-title":"Diversity of native nicotinic receptor subtypes in mammalian brain","volume":"96","author":"Zoli","year":"2015","journal-title":"Neuropharmacology"},{"issue":"4","key":"10.1016\/j.phrs.2021.105700_bib17","doi-asserted-by":"crossref","first-page":"2559","DOI":"10.1074\/jbc.M112.436337","article-title":"Molecular determinants of subtype-selective efficacies of cytisine and the novel compound NS3861 at heteromeric nicotinic acetylcholine receptors","volume":"288","author":"Harpsoe","year":"2013","journal-title":"J. Biol. Chem."},{"issue":"21","key":"10.1016\/j.phrs.2021.105700_bib18","doi-asserted-by":"crossref","first-page":"7820","DOI":"10.1523\/JNEUROSCI.23-21-07820.2003","article-title":"Subunit composition of functional nicotinic receptors in dopaminergic neurons investigated with knock-out mice","volume":"23","author":"Champtiaux","year":"2003","journal-title":"J. Neurosci."},{"issue":"3","key":"10.1016\/j.phrs.2021.105700_bib19","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1016\/0306-4522(94)90484-7","article-title":"Localization of nicotinic cholinergic receptors in rat brain: autoradiographic studies with [3H]cytisine","volume":"62","author":"Happe","year":"1994","journal-title":"Neuroscience"},{"issue":"8","key":"10.1016\/j.phrs.2021.105700_bib20","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1016\/j.bcp.2011.04.019","article-title":"An autoradiographic survey of mouse brain nicotinic acetylcholine receptors defined by null mutants","volume":"82","author":"Baddick","year":"2011","journal-title":"Biochem. Pharmacol."},{"issue":"2","key":"10.1016\/j.phrs.2021.105700_bib21","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1111\/j.1476-5381.2010.00682.x","article-title":"Pre-clinical properties of the alpha4beta2 nicotinic acetylcholine receptor partial agonists varenicline, cytisine and dianicline translate to clinical efficacy for nicotine dependence","volume":"160","author":"Rollema","year":"2010","journal-title":"Br. J. Pharmacol."},{"issue":"4","key":"10.1016\/j.phrs.2021.105700_bib22","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1111\/j.1476-5381.2012.02204.x","article-title":"CC4, a dimer of cytisine, is a selective partial agonist at alpha4beta2\/alpha6beta2 nAChR with improved selectivity for tobacco smoking cessation","volume":"168","author":"Sala","year":"2013","journal-title":"Br. J. Pharmacol."},{"issue":"5","key":"10.1016\/j.phrs.2021.105700_bib23","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1046\/j.1471-4159.2001.00481.x","article-title":"Activity of cytisine and its brominated isosteres on recombinant human alpha7, alpha4beta2 and alpha4beta4 nicotinic acetylcholine receptors","volume":"78","author":"Houlihan","year":"2001","journal-title":"J. Neurochem."},{"issue":"1","key":"10.1016\/j.phrs.2021.105700_bib24","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/S0026-895X(25)09896-7","article-title":"Partial agonist properties of cytisine on neuronal nicotinic receptors containing the beta 2 subunit","volume":"45","author":"Papke","year":"1994","journal-title":"Mol. Pharmacol."},{"issue":"4","key":"10.1016\/j.phrs.2021.105700_bib25","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1016\/j.neuropharm.2012.04.035","article-title":"Use of an alpha3beta4 nicotinic acetylcholine receptor subunit concatamer to characterize ganglionic receptor subtypes with specific subunit composition reveals species-specific pharmacologic properties","volume":"63","author":"Stokes","year":"2012","journal-title":"Neuropharmacology"},{"issue":"4","key":"10.1016\/j.phrs.2021.105700_bib26","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1002\/neu.10145","article-title":"Nicotinic mechanisms in the autonomic control of organ systems","volume":"53","author":"De\u00a0Biasi","year":"2002","journal-title":"J. Neurobiol."},{"issue":"4","key":"10.1016\/j.phrs.2021.105700_bib27","doi-asserted-by":"crossref","first-page":"338","DOI":"10.2174\/1570159X15666170912110450","article-title":"Neuronal and extraneuronal nicotinic acetylcholine receptors","volume":"16","author":"Zoli","year":"2018","journal-title":"Curr. Neuropharmacol."},{"issue":"6","key":"10.1016\/j.phrs.2021.105700_bib28","doi-asserted-by":"crossref","first-page":"1526","DOI":"10.1124\/mol.65.6.1526","article-title":"Subunit composition and pharmacology of two classes of striatal presynaptic nicotinic acetylcholine receptors mediating dopamine release in mice","volume":"65","author":"Salminen","year":"2004","journal-title":"Mol. Pharmacol."},{"issue":"4","key":"10.1016\/j.phrs.2021.105700_bib29","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/j.pneurobio.2007.12.005","article-title":"It is not \u201ceither\/or\u201d: activation and desensitization of nicotinic acetylcholine receptors both contribute to behaviors related to nicotine addiction and mood","volume":"84","author":"Picciotto","year":"2008","journal-title":"Prog. Neurobiol."},{"issue":"1","key":"10.1016\/j.phrs.2021.105700_bib30","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.neuron.2012.08.036","article-title":"Acetylcholine as a neuromodulator: cholinergic signaling shapes nervous system function and behavior","volume":"76","author":"Picciotto","year":"2012","journal-title":"Neuron"},{"issue":"8","key":"10.1016\/j.phrs.2021.105700_bib31","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1016\/j.bcp.2013.06.023","article-title":"Biogenesis, trafficking and up-regulation of nicotinic ACh receptors","volume":"86","author":"Colombo","year":"2013","journal-title":"Biochem. Pharmacol."},{"issue":"2","key":"10.1016\/j.phrs.2021.105700_bib32","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1124\/mol.106.023044","article-title":"alpha4beta2 nicotinic receptors with high and low acetylcholine sensitivity: pharmacology, stoichiometry, and sensitivity to long-term exposure to nicotine","volume":"70","author":"Moroni","year":"2006","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.phrs.2021.105700_bib33","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1016\/j.neuropharm.2016.04.048","article-title":"In vivo chronic nicotine exposure differentially and reversibly affects upregulation and stoichiometry of alpha4beta2 nicotinic receptors in cortex and thalamus","volume":"108","author":"Fasoli","year":"2016","journal-title":"Neuropharmacology"},{"issue":"6","key":"10.1016\/j.phrs.2021.105700_bib34","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1124\/mol.112.077792","article-title":"Pharmacological chaperoning of nicotinic acetylcholine receptors reduces the endoplasmic reticulum stress response","volume":"81","author":"Srinivasan","year":"2012","journal-title":"Mol. Pharmacol."},{"issue":"11","key":"10.1016\/j.phrs.2021.105700_bib35","doi-asserted-by":"crossref","first-page":"1869","DOI":"10.1111\/bph.13777","article-title":"Proteins and chemical chaperones involved in neuronal nicotinic receptor expression and function: an update","volume":"175","author":"Crespi","year":"2018","journal-title":"Br. J. Pharmacol."},{"issue":"30","key":"10.1016\/j.phrs.2021.105700_bib36","doi-asserted-by":"crossref","first-page":"12316","DOI":"10.1523\/JNEUROSCI.2393-13.2013","article-title":"Nicotine-modulated subunit stoichiometry affects stability and trafficking of alpha3beta4 nicotinic receptor","volume":"33","author":"Mazzo","year":"2013","journal-title":"J. Neurosci."},{"issue":"8","key":"10.1016\/j.phrs.2021.105700_bib37","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1038\/sj.bjp.0706434","article-title":"Long-term exposure to the new nicotinic antagonist 1,2-bisN-cytisinylethane upregulates nicotinic receptor subtypes of SH-SY5Y human neuroblastoma cells","volume":"146","author":"Riganti","year":"2005","journal-title":"Br. J. Pharmacol."},{"issue":"6672","key":"10.1016\/j.phrs.2021.105700_bib38","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/S0140-6736(51)91315-3","article-title":"Laburnum poisoning in children; report on ten cases","volume":"2","author":"Mitchell","year":"1951","journal-title":"Lancet"},{"issue":"3","key":"10.1016\/j.phrs.2021.105700_bib39","doi-asserted-by":"crossref","first-page":"e41","DOI":"10.1016\/j.jemermed.2017.04.033","article-title":"Poisoning after ingestion of spartium junceum seeds: dose-dependent effects in three boys","volume":"53","author":"Gimenez","year":"2017","journal-title":"J. Emerg. Med."},{"issue":"4","key":"10.1016\/j.phrs.2021.105700_bib40","first-page":"369","article-title":"Spartium junceum L. poisoning in small ruminants","volume":"55","author":"Ariano","year":"2019","journal-title":"Vet. Ital."},{"issue":"8","key":"10.1016\/j.phrs.2021.105700_bib41","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1080\/15563650903252186","article-title":"Nicotinic plant poisoning","volume":"47","author":"Schep","year":"2009","journal-title":"Clin. Toxicol."},{"key":"10.1016\/j.phrs.2021.105700_bib42","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.etp.2017.01.003","article-title":"Hepatotoxicity induced by radix Sophorae tonkinensis in mice and increased serum cholinesterase as a potential supplemental biomarker for liver injury","volume":"6","author":"Wang","year":"2017","journal-title":"Exp. Toxicol. Pathol."},{"key":"10.1016\/j.phrs.2021.105700_bib43","doi-asserted-by":"crossref","first-page":"1332","DOI":"10.1080\/00498254.2018.1557760","article-title":"Ascending single dose pharmacokinetics of cytisine in healthy adult smokers","volume":"49","author":"Jeong","year":"2019","journal-title":"Xenobiotica"},{"issue":"1\u20132","key":"10.1016\/j.phrs.2021.105700_bib44","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/S0166-4328(00)00200-X","article-title":"Genetic and pharmacological strategies identify a behavioral function of neuronal nicotinic receptors","volume":"113","author":"Stitzel","year":"2000","journal-title":"Behav. Brain Res."},{"issue":"1","key":"10.1016\/j.phrs.2021.105700_bib45","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/S1734-1140(13)70978-2","article-title":"Cytisine inhibits the anticonvulsant activity of phenytoin and lamotrigine in mice","volume":"65","author":"Tutka","year":"2013","journal-title":"Pharmacol. Rep."},{"issue":"2","key":"10.1016\/j.phrs.2021.105700_bib46","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1007\/s00213-016-4461-0","article-title":"Cytisine inhibits the protective activity of various classical and novel antiepileptic drugs against 6 Hz-induced psychomotor seizures in mice","volume":"234","author":"Tutka","year":"2017","journal-title":"Psychopharmacology"},{"issue":"5","key":"10.1016\/j.phrs.2021.105700_bib47","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1002\/jms.1191","article-title":"Detection and validated quantification of toxic alkaloids in human blood plasma--comparison of LC-APCI-MS with LC-ESI-MS\/MS","volume":"42","author":"Beyer","year":"2007","journal-title":"J. Mass Spectrom."},{"key":"10.1016\/j.phrs.2021.105700_bib48","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.jchromb.2013.10.020","article-title":"Simultaneous detection of 22 toxic plant alkaloids (aconitum alkaloids, solanaceous tropane alkaloids, sophora alkaloids, strychnos alkaloids and colchicine) in human urine and herbal samples using liquid chromatography-tandem mass spectrometry","volume":"942\u2013943","author":"Ng","year":"2013","journal-title":"J. Chromatogr. B Anal. Technol. Biomed. Life Sci."},{"issue":"1","key":"10.1016\/j.phrs.2021.105700_bib49","doi-asserted-by":"crossref","first-page":"15","DOI":"10.2478\/v10102-010-0003-5","article-title":"Pharmacokinetics of cytisine after single intravenous and oral administration in rabbits","volume":"3","author":"Astroug","year":"2010","journal-title":"Interdiscip. Toxicol."},{"issue":"14","key":"10.1016\/j.phrs.2021.105700_bib50","doi-asserted-by":"crossref","DOI":"10.3390\/molecules24142580","article-title":"Comparison of various chromatographic systems for analysis of cytisine in human serum, saliva and pharmaceutical formulation by HPLC with diode array, fluorescence or mass spectrometry detection","volume":"24","author":"Wroblewski","year":"2019","journal-title":"Molecules"},{"key":"10.1016\/j.phrs.2021.105700_bib51","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1007\/978-3-642-67729-8_63","article-title":"Pharmacokinetic studies with 3H-cytisine","volume":"4","author":"Klocking","year":"1980","journal-title":"Arch. Toxicol. Suppl."},{"issue":"6","key":"10.1016\/j.phrs.2021.105700_bib52","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1002\/dta.1707","article-title":"Pharmacokinetics of cytisine, an alpha4 beta2 nicotinic receptor partial agonist, in healthy smokers following a single dose","volume":"7","author":"Jeong","year":"2015","journal-title":"Drug Test. Anal."},{"key":"10.1016\/j.phrs.2021.105700_bib53","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.jmgm.2015.11.003","article-title":"Cytisine basicity, solvation, logP, and logD theoretical determination as tool for bioavailability prediction","volume":"63","author":"Pienko","year":"2016","journal-title":"J. Mol. Graph. Model."},{"key":"10.1016\/j.phrs.2021.105700_bib54","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.bbr.2019.03.019","article-title":"Alpha-7 nicotinic receptor allosteric modulator PNU120596 prevents lipopolysaccharide-induced anxiety, cognitive deficit and depression-like behaviors in mice","volume":"366","author":"Alzarea","year":"2019","journal-title":"Behav. Brain Res."},{"issue":"18","key":"10.1016\/j.phrs.2021.105700_bib55","doi-asserted-by":"crossref","first-page":"1752","DOI":"10.1056\/NEJMc1302783","article-title":"Smoking-related mortality in the United States","volume":"368","author":"Lippi","year":"2013","journal-title":"N. Engl. J. Med."},{"issue":"4","key":"10.1016\/j.phrs.2021.105700_bib56","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1056\/NEJMsa1211127","article-title":"50-year trends in smoking-related mortality in the United States","volume":"368","author":"Thun","year":"2013","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.phrs.2021.105700_bib57","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.pneurobio.2014.10.002","article-title":"Nicotinic, glutamatergic and dopaminergic synaptic transmission and plasticity in the mesocorticolimbic system: focus on nicotine effects","volume":"124","author":"Pistillo","year":"2015","journal-title":"Prog. Neurobiol."},{"issue":"6","key":"10.1016\/j.phrs.2021.105700_bib58","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1038\/nrc3725","article-title":"Connections of nicotine to cancer","volume":"14","author":"Grando","year":"2014","journal-title":"Nat. Rev. Cancer"},{"issue":"14","key":"10.1016\/j.phrs.2021.105700_bib59","doi-asserted-by":"crossref","first-page":"2160","DOI":"10.2174\/1381612822666160203144114","article-title":"Neuronal acetylcholine nicotinic receptors as new targets for lung cancer treatment","volume":"22","author":"Mucchietto","year":"2016","journal-title":"Curr. Pharm. Des."},{"issue":"3","key":"10.1016\/j.phrs.2021.105700_bib60","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1038\/nrc2590","article-title":"Is cancer triggered by altered signalling of nicotinic acetylcholine receptors?","volume":"9","author":"Shuller","year":"2009","journal-title":"Nat. Rev. Cancer"},{"issue":"10","key":"10.1016\/j.phrs.2021.105700_bib61","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1007\/s40263-016-0362-3","article-title":"New pharmacological agents to aid smoking cessation and tobacco harm reduction: what has been investigated, and what is in the pipeline?","volume":"30","author":"Beard","year":"2016","journal-title":"CNS Drugs"},{"key":"10.1016\/j.phrs.2021.105700_bib62","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1146\/annurev-med-111314-033712","article-title":"The past, present, and future of nicotine addiction therapy","volume":"67","author":"Prochaska","year":"2016","journal-title":"Annu. Rev. Med."},{"issue":"1","key":"10.1016\/j.phrs.2021.105700_bib63","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1038\/s41533-017-0039-5","article-title":"Treating tobacco dependence: guidance for primary care on life-saving interventions. Position statement of the IPCRG","volume":"27","author":"Van Schayck","year":"2017","journal-title":"NPJ Prim. Care Respir. Med."},{"key":"10.1016\/j.phrs.2021.105700_bib64","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1007\/164_2019_253","article-title":"Randomized clinical trials investigating innovative interventions for smoking cessation in the last decade","volume":"258","author":"Gendy","year":"2020","journal-title":"Handb. Exp. Pharmacol."},{"issue":"10","key":"10.1016\/j.phrs.2021.105700_bib65","doi-asserted-by":"crossref","first-page":"3474","DOI":"10.1021\/jm050069n","article-title":"Varenicline: an alpha4beta2 nicotinic receptor partial agonist for smoking cessation","volume":"48","author":"Coe","year":"2005","journal-title":"J. Med. Chem."},{"issue":"2","key":"10.1016\/j.phrs.2021.105700_bib66","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1002\/phar.2073","article-title":"Current and emerging pharmacotherapies for cessation of tobacco smoking","volume":"38","author":"Gomez-Coronado","year":"2018","journal-title":"Pharmacotherapy"},{"issue":"1\u20133","key":"10.1016\/j.phrs.2021.105700_bib67","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.drugalcdep.2007.06.017","article-title":"Cytisine for smoking cessation: a research agenda","volume":"92","author":"Etter","year":"2008","journal-title":"Drug Alcohol Depend."},{"issue":"13","key":"10.1016\/j.phrs.2021.105700_bib68","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1056\/NEJMoa1102035","article-title":"Placebo-controlled trial of cytisine for smoking cessation","volume":"365","author":"West","year":"2011","journal-title":"N. Engl. J. Med."},{"issue":"11","key":"10.1016\/j.phrs.2021.105700_bib69","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1056\/NEJMc1500342","article-title":"Cytisine versus nicotine for smoking cessation","volume":"372","author":"Zatonski","year":"2015","journal-title":"N. Engl. J. Med."},{"issue":"11","key":"10.1016\/j.phrs.2021.105700_bib70","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1136\/thoraxjnl-2012-203035","article-title":"Efficacy of cytisine in helping smokers quit: systematic review and meta-analysis","volume":"68","author":"Hajek","year":"2013","journal-title":"Thorax"},{"issue":"4","key":"10.1016\/j.phrs.2021.105700_bib71","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1136\/eb-2013-101696","article-title":"Cytisine is effective for smoking cessation: should clinicians use it?","volume":"19","author":"Samet","year":"2014","journal-title":"Evid. Based Med."},{"issue":"7","key":"10.1016\/j.phrs.2021.105700_bib72","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1016\/j.tips.2007.05.003","article-title":"Rationale, pharmacology and clinical efficacy of partial agonists of alpha4beta2 nACh receptors for smoking cessation","volume":"28","author":"Rollema","year":"2007","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.phrs.2021.105700_bib73","article-title":"Nicotine receptor partial agonists for smoking cessation","volume":"5","author":"Cahill","year":"2016","journal-title":"Cochrane Database Syst. Rev."},{"issue":"33","key":"10.1016\/j.phrs.2021.105700_bib74","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3310\/hta18330","article-title":"What is the clinical effectiveness and cost-effectiveness of cytisine compared with varenicline for smoking cessation? A systematic review and economic evaluation","volume":"18","author":"Leaviss","year":"2014","journal-title":"Health Technol. Assess."},{"key":"10.1016\/j.phrs.2021.105700_bib75","doi-asserted-by":"crossref","DOI":"10.1111\/add.15489","article-title":"Cytisine versus varenicline for smoking cessation in New Zealand indigenous M\u0101ori: a randomized controlled trial","author":"Walker","year":"2021","journal-title":"Addiction"},{"issue":"1","key":"10.1016\/j.phrs.2021.105700_bib76","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1186\/s13287-018-1126-4","article-title":"An integrated characterization of contractile, electrophysiological, and structural cardiotoxicity of Sophora tonkinensis Gapnep. in human pluripotent stem cell-derived cardiomyocytes","volume":"10","author":"Wang","year":"2019","journal-title":"Stem Cell Res. Ther."},{"issue":"1","key":"10.1016\/j.phrs.2021.105700_bib77","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/S0376-8716(96)01315-4","article-title":"Prevalence and demographic correlates of symptoms of last year dependence on alcohol, nicotine, marijuana and cocaine in the U.S. population","volume":"44","author":"Kandel","year":"1997","journal-title":"Drug Alcohol Depend."},{"issue":"6","key":"10.1016\/j.phrs.2021.105700_bib78","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1093\/alcalc\/agg122","article-title":"Strength of the relationship between tobacco smoking, nicotine dependence and the severity of alcohol dependence syndrome criteria in a population-based sample","volume":"38","author":"John","year":"2003","journal-title":"Alcohol Alcohol."},{"issue":"2\u20133","key":"10.1016\/j.phrs.2021.105700_bib79","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.drugalcdep.2007.05.016","article-title":"Subtypes of alcohol dependence in a nationally representative sample","volume":"91","author":"Moss","year":"2007","journal-title":"Drug Alcohol Depend."},{"issue":"5","key":"10.1016\/j.phrs.2021.105700_bib80","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1093\/alcalc\/agm057","article-title":"Combined effects of systemic alcohol and nicotine on dopamine release in the nucleus accumbens shell","volume":"42","author":"Tizabi","year":"2007","journal-title":"Alcohol Alcohol."},{"issue":"5","key":"10.1016\/j.phrs.2021.105700_bib81","doi-asserted-by":"crossref","first-page":"647","DOI":"10.2174\/1871527314666150429112954","article-title":"Targeting brain nicotinic acetylcholine receptors to treat major depression and co-morbid alcohol or nicotine addiction","volume":"14","author":"Rahman","year":"2015","journal-title":"CNS Neurol. Disord. Drug Targets"},{"issue":"1","key":"10.1016\/j.phrs.2021.105700_bib82","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00213-010-1932-6","article-title":"Nicotinic acetylcholine receptors and depression: a review of the preclinical and clinical literature","volume":"212","author":"Philip","year":"2010","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.phrs.2021.105700_bib83","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/bs.pmbts.2015.10.004","article-title":"Recent advances in nicotinic receptor signaling in alcohol abuse and alcoholism","volume":"137","author":"Rahman","year":"2016","journal-title":"Prog. Mol. Biol. Transl. Sci."},{"key":"10.1016\/j.phrs.2021.105700_bib84","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.brainresbull.2020.07.017","article-title":"The role of nicotinic acetylcholine receptors in alcohol-related behaviors","volume":"163","author":"Miller","year":"2020","journal-title":"Brain Res. Bull."},{"key":"10.1016\/j.phrs.2021.105700_bib85","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.neuropharm.2019.01.021","article-title":"Alpha6-containing nicotinic acetylcholine receptor is a highly sensitive target of alcohol","volume":"149","author":"Gao","year":"2019","journal-title":"Neuropharmacology"},{"issue":"3","key":"10.1016\/j.phrs.2021.105700_bib86","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1097\/01.ALC.0000156116.40817.A2","article-title":"Deletion of the alpha7 nicotinic receptor subunit gene results in increased sensitivity to several behavioral effects produced by alcohol","volume":"29","author":"Bowers","year":"2005","journal-title":"Alcohol Clin. Exp. Res."},{"issue":"30","key":"10.1016\/j.phrs.2021.105700_bib87","doi-asserted-by":"crossref","first-page":"12518","DOI":"10.1073\/pnas.0705368104","article-title":"Varenicline, an alpha4beta2 nicotinic acetylcholine receptor partial agonist, selectively decreases ethanol consumption and seeking","volume":"104","author":"Steensland","year":"2007","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"2","key":"10.1016\/j.phrs.2021.105700_bib88","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.biopsych.2009.01.029","article-title":"Varenicline reduces alcohol self-administration in heavy-drinking smokers","volume":"66","author":"McKee","year":"2009","journal-title":"Biol. Psychiatry"},{"issue":"2","key":"10.1016\/j.phrs.2021.105700_bib89","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1007\/s00213-013-2974-3","article-title":"Varenicline and cytisine: two nicotinic acetylcholine receptor ligands reduce ethanol intake in University of Chile bibulous rats","volume":"227","author":"Sotomayor-Zarate","year":"2013","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.phrs.2021.105700_bib90","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.pbb.2013.07.009","article-title":"Nicotinic receptor partial agonists modulate alcohol deprivation effect in C57BL\/6J mice","volume":"110","author":"Sajja","year":"2013","journal-title":"Pharmacol. Biochem. Behav."},{"issue":"30","key":"10.1016\/j.phrs.2021.105700_bib91","doi-asserted-by":"crossref","first-page":"10169","DOI":"10.1523\/JNEUROSCI.2601-10.2010","article-title":"Activation of alpha4* nAChRs is necessary and sufficient for varenicline-induced reduction of alcohol consumption","volume":"30","author":"Hendrickson","year":"2010","journal-title":"J. Neurosci."},{"issue":"1","key":"10.1016\/j.phrs.2021.105700_bib92","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1097\/01.ALC.0000150007.34702.16","article-title":"Mecamylamine and ethanol preference in healthy volunteers","volume":"29","author":"Young","year":"2005","journal-title":"Alcohol Clin. Exp. Res."},{"issue":"3","key":"10.1016\/j.phrs.2021.105700_bib93","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1038\/npp.2010.191","article-title":"Partial agonists of the alpha3beta4* neuronal nicotinic acetylcholine receptor reduce ethanol consumption and seeking in rats","volume":"36","author":"Chatterjee","year":"2011","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.phrs.2021.105700_bib94","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.alcohol.2018.11.006","article-title":"The alpha3beta4 nicotinic acetylcholine receptor antagonist 18-Methoxycoronaridine decreases binge-like ethanol consumption in adult C57BL\/6J mice","volume":"79","author":"Miller","year":"2019","journal-title":"Alcohol"},{"issue":"4","key":"10.1016\/j.phrs.2021.105700_bib95","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/j.alcohol.2013.02.003","article-title":"Cytisine modulates chronic voluntary ethanol consumption and ethanol-induced striatal up-regulation of DeltaFosB in mice","volume":"47","author":"Sajja","year":"2013","journal-title":"Alcohol"},{"issue":"12","key":"10.1016\/j.phrs.2021.105700_bib96","doi-asserted-by":"crossref","first-page":"2017","DOI":"10.1111\/j.1530-0277.2006.00248.x","article-title":"Development of an alcohol deprivation and escalation effect in C57BL\/6J mice","volume":"30","author":"Melendez","year":"2006","journal-title":"Alcohol Clin. Exp. Res."},{"issue":"11","key":"10.1016\/j.phrs.2021.105700_bib97","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1038\/nrn3111","article-title":"Transcriptional and epigenetic mechanisms of addiction","volume":"12","author":"Robison","year":"2011","journal-title":"Nat. Rev. Neurosci."},{"issue":"4","key":"10.1016\/j.phrs.2021.105700_bib98","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/j.conb.2013.01.001","article-title":"Epigenetic mechanisms of drug addiction","volume":"23","author":"Feng","year":"2013","journal-title":"Curr. Opin. Neurobiol."},{"key":"10.1016\/j.phrs.2021.105700_bib99","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2019.103032","article-title":"Novel cytisine derivatives exert anti-liver fibrosis effect via PI3K\/Akt\/Smad pathway","volume":"90","author":"Tang","year":"2019","journal-title":"Bioorg. Chem."},{"issue":"2","key":"10.1016\/j.phrs.2021.105700_bib100","doi-asserted-by":"crossref","first-page":"147","DOI":"10.35946\/arcr.v38.2.01","article-title":"Alcoholic liver disease: pathogenesis and current management","volume":"38","author":"Osna","year":"2017","journal-title":"Alcohol Res."},{"key":"10.1016\/j.phrs.2021.105700_bib101","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/j.neuropharm.2015.03.019","article-title":"Agonist and antagonist effects of cytisine in vivo","volume":"95","author":"Radchenko","year":"2015","journal-title":"Neuropharmacology"},{"issue":"2","key":"10.1016\/j.phrs.2021.105700_bib102","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1038\/npp.2013.216","article-title":"Varenicline and cytisine diminish the dysphoric-like state associated with spontaneous nicotine withdrawal in rats","volume":"39","author":"Igari","year":"2014","journal-title":"Neuropsychopharmacology"},{"issue":"3","key":"10.1016\/j.phrs.2021.105700_bib103","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1007\/s002130050188","article-title":"Discriminative stimulus properties of the nicotinic agonist cytisine","volume":"129","author":"Chandler","year":"1997","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.phrs.2021.105700_bib104","doi-asserted-by":"crossref","DOI":"10.3389\/fnbeh.2020.570704","article-title":"Elemental and configural associative learning in spatial tasks: could zebrafish be used to advance our knowledge?","volume":"14","author":"Buatois","year":"2020","journal-title":"Front. Behav. Neurosci."},{"issue":"4","key":"10.1016\/j.phrs.2021.105700_bib105","doi-asserted-by":"crossref","first-page":"423","DOI":"10.2174\/1568007023339102","article-title":"Nicotinic treatment for cognitive dysfunction","volume":"1","author":"Levin","year":"2002","journal-title":"Curr. Drug Targets CNS Neurol. Disord."},{"issue":"3\u20134","key":"10.1016\/j.phrs.2021.105700_bib106","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1007\/s002130050667","article-title":"Nicotinic acetylcholine involvement in cognitive function in animals","volume":"138","author":"Levin","year":"1998","journal-title":"Psychopharmacology"},{"issue":"9","key":"10.1016\/j.phrs.2021.105700_bib107","doi-asserted-by":"crossref","first-page":"1975","DOI":"10.1007\/s00213-013-3340-1","article-title":"Role of neuronal nicotinic acetylcholine receptors (nAChRs) on learning and memory in zebrafish","volume":"231","author":"Braida","year":"2014","journal-title":"Psychopharmacology"},{"issue":"6035","key":"10.1016\/j.phrs.2021.105700_bib108","doi-asserted-by":"crossref","first-page":"1330","DOI":"10.1126\/science.1201889","article-title":"Nicotine decreases food intake through activation of POMC neurons","volume":"332","author":"Mineur","year":"2011","journal-title":"Science"},{"issue":"9","key":"10.1016\/j.phrs.2021.105700_bib109","doi-asserted-by":"crossref","first-page":"3573","DOI":"10.1073\/pnas.1219731110","article-title":"Cholinergic signaling in the hippocampus regulates social stress resilience and anxiety- and depression-like behavior","volume":"110","author":"Mineur","year":"2013","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"20","key":"10.1016\/j.phrs.2021.105700_bib110","doi-asserted-by":"crossref","first-page":"3792","DOI":"10.2174\/0929867325666180410105135","article-title":"NAChR alpha4beta2 subtype and their relation with nicotine addiction, cognition, depression and hyperactivity disorder","volume":"26","author":"Laikowski","year":"2019","journal-title":"Curr. Med. Chem."},{"issue":"5","key":"10.1016\/j.phrs.2021.105700_bib111","doi-asserted-by":"crossref","DOI":"10.4088\/JCP.18m12137","article-title":"Transdermal nicotine for the treatment of mood and cognitive symptoms in nonsmokers with late-life depression","volume":"79","author":"Gandelman","year":"2018","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.phrs.2021.105700_bib112","doi-asserted-by":"crossref","first-page":"2118","DOI":"10.1038\/s41386-018-0024-x","article-title":"Interaction between noradrenergic and cholinergic signaling in amygdala regulates anxiety- and depression-related behaviors in mice","volume":"43","author":"Mineur","year":"2018","journal-title":"Neuropsychopharmacology"},{"issue":"3","key":"10.1016\/j.phrs.2021.105700_bib113","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1016\/j.pbb.2011.11.004","article-title":"Combined alpha7 nicotinic acetylcholine receptor agonism and partial serotonin transporter inhibition produce antidepressant-like effects in the mouse forced swim and tail suspension tests: a comparison of SSR180711 and PNU-282987","volume":"100","author":"Andreasen","year":"2012","journal-title":"Pharmacol. Biochem. Behav."},{"issue":"5","key":"10.1016\/j.phrs.2021.105700_bib114","doi-asserted-by":"crossref","first-page":"1256","DOI":"10.1016\/j.neuropharm.2007.01.006","article-title":"Cytisine, a partial agonist of high-affinity nicotinic acetylcholine receptors, has antidepressant-like properties in male C57BL\/6J mice","volume":"52","author":"Mineur","year":"2007","journal-title":"Neuropharmacology"},{"issue":"4","key":"10.1016\/j.phrs.2021.105700_bib115","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1097\/FBP.0b013e328347546d","article-title":"alpha4beta2 nicotinic acetylcholine receptor partial agonists with low intrinsic efficacy have antidepressant-like properties","volume":"22","author":"Mineur","year":"2011","journal-title":"Behav. Pharmacol."},{"issue":"11","key":"10.1016\/j.phrs.2021.105700_bib116","doi-asserted-by":"crossref","first-page":"1903","DOI":"10.1111\/bph.13769","article-title":"Hippocampal alpha7 nicotinic ACh receptors contribute to modulation of depression-like behaviour in C57BL\/6J mice","volume":"175","author":"Mineur","year":"2018","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.phrs.2021.105700_bib117","doi-asserted-by":"crossref","DOI":"10.1100\/2012\/104105","article-title":"The nicotinic acetylcholine receptor as a target for antidepressant drug development","volume":"2012","author":"Philip","year":"2012","journal-title":"Sci. World J."},{"issue":"3","key":"10.1016\/j.phrs.2021.105700_bib118","doi-asserted-by":"crossref","first-page":"291","DOI":"10.4062\/biomolther.2015.113","article-title":"Cytisine, a partial agonist of alpha4beta2 nicotinic acetylcholine receptors, reduced unpredictable chronic mild stress-induced depression-like behaviors","volume":"24","author":"Han","year":"2016","journal-title":"Biomol. Ther."},{"issue":"1","key":"10.1016\/j.phrs.2021.105700_bib119","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1124\/jpet.108.149609","article-title":"Cytisine-based nicotinic partial agonists as novel antidepressant compounds","volume":"329","author":"Mineur","year":"2009","journal-title":"J. Pharmacol. Exp. Ther."},{"issue":"20","key":"10.1016\/j.phrs.2021.105700_bib120","doi-asserted-by":"crossref","first-page":"8204","DOI":"10.1021\/jm401937a","article-title":"Recent developments in novel antidepressants targeting alpha4beta2-nicotinic acetylcholine receptors","volume":"57","author":"Yu","year":"2014","journal-title":"J. Med. Chem."},{"issue":"1\u20133","key":"10.1016\/j.phrs.2021.105700_bib121","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.ejphar.2009.01.002","article-title":"Varenicline has antidepressant-like activity in the forced swim test and augments sertraline\u2019s effect","volume":"605","author":"Rollema","year":"2009","journal-title":"Eur. J. Pharmacol."},{"issue":"4","key":"10.1016\/j.phrs.2021.105700_bib122","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1038\/npp.2014.269","article-title":"Expression of the 5-HT1A serotonin receptor in the hippocampus is required for social stress resilience and the antidepressant-like effects induced by the nicotinic partial agonist cytisine","volume":"40","author":"Mineur","year":"2015","journal-title":"Neuropsychopharmacology"},{"issue":"5","key":"10.1016\/j.phrs.2021.105700_bib123","doi-asserted-by":"crossref","first-page":"3295","DOI":"10.1007\/s12035-018-1283-6","article-title":"Brain-derived neurotrophic factor in brain disorders: focus on neuroinflammation","volume":"56","author":"Lima Giacobbo","year":"2019","journal-title":"Mol. Neurobiol."},{"issue":"3","key":"10.1016\/j.phrs.2021.105700_bib124","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1097\/JCP.0b013e318172b49e","article-title":"Nicotinic antagonist augmentation of selective serotonin reuptake inhibitor-refractory major depressive disorder: a preliminary study","volume":"28","author":"George","year":"2008","journal-title":"J. Clin. Psychopharmacol."},{"issue":"7","key":"10.1016\/j.phrs.2021.105700_bib125","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.4088\/JCP.08m04441","article-title":"Varenicline augmentation in depressed smokers: an 8-week, open-label study","volume":"70","author":"Philip","year":"2009","journal-title":"J. Clin. Psychiatry"},{"issue":"5","key":"10.1016\/j.phrs.2021.105700_bib126","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1097\/YIC.0000000000000128","article-title":"Ineffectiveness of nicotinic acetylcholine receptor antagonists for treatment-resistant depression: a meta-analysis","volume":"31","author":"Wang","year":"2016","journal-title":"Int. Clin. Psychopharmacol."},{"key":"10.1016\/j.phrs.2021.105700_bib127","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/j.neubiorev.2017.08.018","article-title":"Nicotine and networks: potential for enhancement of mood and cognition in late-life depression","volume":"84","author":"Gandelman","year":"2018","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/j.phrs.2021.105700_bib128","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/j.pbb.2013.07.012","article-title":"The effects of noncontingent and self-administered cytisine on body weight and meal patterns in male Sprague-Dawley rats","volume":"110","author":"Grebenstein","year":"2013","journal-title":"Pharmacol. Biochem. Behav."},{"issue":"29","key":"10.1016\/j.phrs.2021.105700_bib129","doi-asserted-by":"crossref","first-page":"10440","DOI":"10.1523\/JNEUROSCI.1110-15.2015","article-title":"Hypothalamic non-AgRP, non-POMC GABAergic neurons are required for postweaning feeding and NPY hyperphagia","volume":"35","author":"Kim","year":"2015","journal-title":"J. Neurosci."},{"issue":"1","key":"10.1016\/j.phrs.2021.105700_bib130","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1038\/nn.4442","article-title":"A rapidly acting glutamatergic ARC-->PVH satiety circuit postsynaptically regulated by alpha-MSH","volume":"20","author":"Fenselau","year":"2017","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.phrs.2021.105700_bib131","doi-asserted-by":"crossref","DOI":"10.1111\/ejn.13966","article-title":"Molecular and cellular characterization of nicotinic acetylcholine receptor subtypes in the arcuate nucleus of the mouse hypothalamus","author":"Calarco","year":"2018","journal-title":"Eur. J. Neurosci."},{"issue":"12","key":"10.1016\/j.phrs.2021.105700_bib132","doi-asserted-by":"crossref","first-page":"1869","DOI":"10.2174\/1381612822666161201145648","article-title":"Levamisole: a positive allosteric modulator for the alpha3beta4 nicotinic acetylcholine receptors prevents weight gain in the CD-1 mice on a high fat diet","volume":"23","author":"Lewis","year":"2017","journal-title":"Curr. Pharm. Des."},{"issue":"1","key":"10.1016\/j.phrs.2021.105700_bib133","doi-asserted-by":"crossref","first-page":"4304","DOI":"10.1038\/s41467-018-06769-y","article-title":"Coordinated targeting of cold and nicotinic receptors synergistically improves obesity and type 2 diabetes","volume":"9","author":"Clemmensen","year":"2018","journal-title":"Nat. Commun."},{"issue":"3","key":"10.1016\/j.phrs.2021.105700_bib134","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0150270","article-title":"Neuronal nicotinic acetylcholine receptor modulators reduce sugar intake","volume":"11","author":"Shariff","year":"2016","journal-title":"PLoS One"},{"issue":"2","key":"10.1016\/j.phrs.2021.105700_bib135","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/0006-8993(94)01286-Q","article-title":"Cytisine-induced behavioral activation: delineation of neuroanatomical locus of action","volume":"670","author":"Museo","year":"1995","journal-title":"Brain Res."},{"issue":"1\u20133","key":"10.1016\/j.phrs.2021.105700_bib136","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.ejphar.2008.05.013","article-title":"In vivo modulation of dopaminergic nigrostriatal pathways by cytisine derivatives: implications for Parkinson\u2019s disease","volume":"589","author":"Abin-Carriquiry","year":"2008","journal-title":"Eur. J. Pharmacol."},{"issue":"1\u20133","key":"10.1016\/j.phrs.2021.105700_bib137","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.ejphar.2010.02.030","article-title":"Increase in locomotor activity after acute administration of the nicotinic receptor agonist 3-bromocytisine in rats","volume":"634","author":"Abin-Carriquiry","year":"2010","journal-title":"Eur. J. Pharmacol."},{"issue":"4","key":"10.1016\/j.phrs.2021.105700_bib138","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1007\/s11065-015-9303-z","article-title":"Preclinical evidence for a role of the nicotinic cholinergic system in Parkinson\u2019s disease","volume":"25","author":"Perez","year":"2015","journal-title":"Neuropsychol. Rev."},{"issue":"6","key":"10.1016\/j.phrs.2021.105700_bib139","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1038\/sj.bjp.0703161","article-title":"Factors influencing the low-frequency associated nicotinic ACh autoreceptor-mediated depression of ACh release from rat motor nerve terminals","volume":"129","author":"Prior","year":"2000","journal-title":"Br. J. Pharmacol."},{"issue":"9","key":"10.1016\/j.phrs.2021.105700_bib140","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1016\/j.tins.2004.06.008","article-title":"Smoking, nicotine and Parkinson\u2019s disease","volume":"27","author":"Quik","year":"2004","journal-title":"Trends Neurosci."},{"issue":"20","key":"10.1016\/j.phrs.2021.105700_bib141","doi-asserted-by":"crossref","first-page":"8785","DOI":"10.1523\/JNEUROSCI.22-20-08785.2002","article-title":"Identification of the nicotinic receptor subtypes expressed on dopaminergic terminals in the rat striatum","volume":"22","author":"Zoli","year":"2002","journal-title":"J. Neurosci."},{"key":"10.1016\/j.phrs.2021.105700_bib142","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/bs.irn.2015.07.005","article-title":"Nicotine and nicotinic receptor drugs: potential for Parkinson\u2019s disease and drug-induced movement disorders","volume":"124","author":"Quik","year":"2015","journal-title":"Int. Rev. Neurobiol."},{"issue":"2\u20133","key":"10.1016\/j.phrs.2021.105700_bib143","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/S0014-2999(98)00696-7","article-title":"Effects of cytisine on hydroxyl radicals in vitro and MPTP-induced dopamine depletion in vivo","volume":"360","author":"Ferger","year":"1998","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.phrs.2021.105700_bib144","article-title":"Cytisine is neuroprotective in female but not male 6-hydroxydopamine lesioned parkinsonian mice and acts in combination with 17-beta-estradiol to inhibit apoptotic endoplasmic reticulum stress in dopaminergic neurons","author":"Zarate","year":"2020","journal-title":"J. Neurochem."},{"issue":"1\u20132","key":"10.1016\/j.phrs.2021.105700_bib145","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/S0166-4328(00)00206-0","article-title":"Smoking and Parkinson\u2019s and Alzheimer\u2019s disease: review of the epidemiological studies","volume":"113","author":"Fratiglioni","year":"2000","journal-title":"Behav. Brain Res."},{"issue":"Suppl. 3","key":"10.1016\/j.phrs.2021.105700_bib146","first-page":"S122","article-title":"Smoking and increased Alzheimer\u2019s disease risk: a review of potential mechanisms","volume":"10","author":"Durazzo","year":"2014","journal-title":"Alzheimers Dement."},{"key":"10.1016\/j.phrs.2021.105700_bib147","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.neuro.2012.09.009","article-title":"Cytisine confers neuronal protection against excitotoxic injury by down-regulating GluN2B-containing NMDA receptors","volume":"34","author":"Li","year":"2013","journal-title":"Neurotoxicology"},{"issue":"8","key":"10.1016\/j.phrs.2021.105700_bib148","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.1007\/s11064-018-2572-1","article-title":"Neuroprotection of cytisine against cerebral ischemia-reperfusion injury in mice by regulating NR2B-ERK\/CREB signal pathway","volume":"43","author":"Zhao","year":"2018","journal-title":"Neurochem. Res."},{"key":"10.1016\/j.phrs.2021.105700_bib149","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1111\/j.1476-5381.1969.tb07977.x","article-title":"Some studies on cytisine and its methylated derivatives","volume":"35","author":"Barlow","year":"1969","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.phrs.2021.105700_bib150","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2020.106496","article-title":"Acute nicotine administration stimulates ciliary activity via \u03b13\u03b24 nAChR in the mouse trachea","volume":"84","author":"Perniss","year":"2020","journal-title":"Int. Immunopharmacol."},{"issue":"7","key":"10.1016\/j.phrs.2021.105700_bib151","doi-asserted-by":"crossref","first-page":"E580","DOI":"10.1152\/ajpendo.00237.2014","article-title":"Partial blockade of nicotinic acetylcholine receptors improves the counterregulatory response to hypoglycemia in recurrently hypoglycemic rats","volume":"307","author":"LaGamma","year":"2014","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"issue":"2","key":"10.1016\/j.phrs.2021.105700_bib152","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1007\/s00213-010-2132-0","article-title":"Effects of 18-methoxycoronaridine on ghrelin-induced increases in sucrose intake and accumbal dopamine overflow in female rats","volume":"215","author":"McCallum","year":"2011","journal-title":"Psychopharmacology"},{"issue":"4","key":"10.1016\/j.phrs.2021.105700_bib153","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1038\/nm.3826","article-title":"Activation of AMPKalpha2 in adipocytes is essential for nicotine-induced insulin resistance in vivo","volume":"21","author":"Wu","year":"2015","journal-title":"Nat. Med."},{"issue":"6","key":"10.1016\/j.phrs.2021.105700_bib154","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.1007\/s00125-020-05117-4","article-title":"Pharmacological targeting of alpha3beta4 nicotinic receptors improves peripheral insulin sensitivity in mice with diet-induced obesity","volume":"63","author":"Jall","year":"2020","journal-title":"Diabetologia"},{"key":"10.1016\/j.phrs.2021.105700_bib155","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1186\/1479-5876-12-153","article-title":"Drug-repurposing identified the combination of trolox C and cytisine for the treatment of type 2 diabetes","volume":"12","author":"Jin","year":"2014","journal-title":"J. Transl. Med."},{"issue":"3","key":"10.1016\/j.phrs.2021.105700_bib156","doi-asserted-by":"crossref","first-page":"1511","DOI":"10.1016\/S0022-3565(25)38237-6","article-title":"Effects of nicotine on brain stem mechanisms of cardiovascular control","volume":"265","author":"Tseng","year":"1993","journal-title":"J. Pharmacol. Exp. Ther."},{"issue":"6","key":"10.1016\/j.phrs.2021.105700_bib157","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1007\/BF00053022","article-title":"Nicotine and sympathetic neurotransmission","volume":"10","author":"Haass","year":"1997","journal-title":"Cardiovasc. Drugs Ther."},{"issue":"3","key":"10.1016\/j.phrs.2021.105700_bib158","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1016\/j.drugalcdep.2012.12.021","article-title":"Patterns of nicotinic receptor antagonism II: cardiovascular effects in rats","volume":"131","author":"Jutkiewicz","year":"2013","journal-title":"Drug Alcohol Depend."},{"issue":"1","key":"10.1016\/j.phrs.2021.105700_bib159","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.ejphar.2010.12.003","article-title":"The effects of nicotine, varenicline, and cytisine on schedule-controlled responding in mice: differences in alpha4beta2 nicotinic receptor activation","volume":"654","author":"Cunningham","year":"2011","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.phrs.2021.105700_bib160","doi-asserted-by":"crossref","first-page":"3059","DOI":"10.3390\/molecules23123059","article-title":"Cytisine-pterocarpan-derived compounds: biomimetic synthesis and apoptosis-inducing activity in human breast cancer cells","volume":"23","author":"Peng","year":"2018","journal-title":"Molecules"},{"issue":"5","key":"10.1016\/j.phrs.2021.105700_bib161","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1111\/j.1742-7843.2010.00653.x","article-title":"In vitro anti-tumour activities of quinolizidine alkaloids derived from Sophora flavescens Ait","volume":"108","author":"Lin","year":"2011","journal-title":"Basic Clin. Pharmacol. Toxicol."},{"issue":"48","key":"10.1016\/j.phrs.2021.105700_bib162","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1080\/21691401.2019.1699813","article-title":"Cytisine exerts anti-tumour effects on lung cancer cells by modulating reactive oxygen species-mediated signalling pathways","author":"Xu","year":"2020","journal-title":"Artif. Cells Nanomed. Biotechnol."},{"issue":"3","key":"10.1016\/j.phrs.2021.105700_bib163","doi-asserted-by":"crossref","first-page":"3363","DOI":"10.3892\/mmr.2017.6991","article-title":"Cytisine induces apoptosis of HepG2 cells","volume":"16","author":"Yu","year":"2017","journal-title":"Mol. Med. Rep."},{"issue":"43","key":"10.1016\/j.phrs.2021.105700_bib164","doi-asserted-by":"crossref","first-page":"17480","DOI":"10.1073\/pnas.1312022110","article-title":"Menin promotes hepatocellular carcinogenesis and epigenetically up-regulates Yap1 transcription","volume":"110","author":"Xu","year":"2013","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"34","key":"10.1016\/j.phrs.2021.105700_bib165","doi-asserted-by":"crossref","first-page":"5788","DOI":"10.1039\/C6CC01079B","article-title":"Structure-based screening and optimization of cytisine derivatives as inhibitors of the menin-MLL interaction","volume":"52","author":"Zhong","year":"2016","journal-title":"Chem. Commun."},{"issue":"17","key":"10.1016\/j.phrs.2021.105700_bib166","doi-asserted-by":"crossref","first-page":"10112","DOI":"10.1111\/jcmm.15622","article-title":"Cytisine attenuates bone loss of ovariectomy mouse by preventing RANKL-induced osteoclastogenesis","volume":"24","author":"Qian","year":"2020","journal-title":"J. Cell. Mol. Med."},{"issue":"7","key":"10.1016\/j.phrs.2021.105700_bib167","doi-asserted-by":"crossref","first-page":"2530","DOI":"10.1172\/JCI94606","article-title":"The many ways of osteoclast activation","volume":"127","author":"Lorenzo","year":"2017","journal-title":"J. Clin. Investig."},{"issue":"1","key":"10.1016\/j.phrs.2021.105700_bib168","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1021\/cr400307e","article-title":"(-)-Cytisine and derivatives: synthesis, reactivity, and applications","volume":"114","author":"Rouden","year":"2014","journal-title":"Chem. Rev."},{"issue":"3","key":"10.1016\/j.phrs.2021.105700_bib169","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/S0014-827X(03)00017-X","article-title":"Cytisine derivatives as ligands for neuronal nicotine receptors and with various pharmacological activities","volume":"58","author":"Boido","year":"2003","journal-title":"Farmaco"},{"issue":"5","key":"10.1016\/j.phrs.2021.105700_bib170","doi-asserted-by":"crossref","first-page":"369","DOI":"10.2174\/1389557519666191104121821","article-title":"Advances on the bioactivities, total synthesis, structural modification, and structure-activity relationships of cytisine derivatives","volume":"20","author":"Huang","year":"2020","journal-title":"Mini-Rev. Med. Chem."},{"issue":"2","key":"10.1016\/j.phrs.2021.105700_bib171","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/S0014-2999(03)01817-X","article-title":"Nitrogen substitution modifies the activity of cytisine on neuronal nicotinic receptor subtypes","volume":"471","author":"Carbonnelle","year":"2003","journal-title":"Eur. J. Pharmacol."},{"issue":"14","key":"10.1016\/j.phrs.2021.105700_bib172","doi-asserted-by":"crossref","first-page":"4345","DOI":"10.1021\/jm900225j","article-title":"Synthesis, binding, and modeling studies of new cytisine derivatives, as ligands for neuronal nicotinic acetylcholine receptor subtypes","volume":"52","author":"Tasso","year":"2009","journal-title":"J. Med. Chem."},{"issue":"7","key":"10.1016\/j.phrs.2021.105700_bib173","doi-asserted-by":"crossref","first-page":"1710","DOI":"10.1016\/j.chempr.2018.05.007","article-title":"Unlocking nicotinic selectivity via direct C\u2013H functionalization of (\u2013)-cytisine","volume":"4","author":"RegoCampello","year":"2018","journal-title":"Chem"},{"issue":"7","key":"10.1016\/j.phrs.2021.105700_bib174","doi-asserted-by":"crossref","first-page":"1651","DOI":"10.1111\/bph.15389","article-title":"A conserved arginine with non-conserved function is a key determinant of agonist selectivity in alpha7 nicotinic ACh receptors","volume":"178","author":"Minguez-Vinas","year":"2021","journal-title":"Br. J. Pharmacol."},{"issue":"4","key":"10.1016\/j.phrs.2021.105700_bib175","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1007\/s10517-018-4006-0","article-title":"Nootropic activity of a novel (-)-cytisine derivative (3aR,4S,8S,12R, 12aS,12bR)-10-methyl-2-phenyloctahydro-1H-4,12a-etheno-8,12-methanopyrrolo[3\u2019,4\u2019:3,4]pyrido[1,2-a] [1,5]diazocine-1,3,5(4H)-trione","volume":"164434\u2013438","author":"Makara","year":"2018","journal-title":"Bull. Exp. Biol. Med."},{"key":"10.1016\/j.phrs.2021.105700_bib176","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1016\/j.toxrep.2019.08.011","article-title":"Three (-)-cytisine derivatives and 1-hydroxyquinopimaric acid as acetylcholinesterase inhibitors","volume":"6","author":"Garcia-Gracia","year":"2019","journal-title":"Toxicol. Rep."},{"key":"10.1016\/j.phrs.2021.105700_bib177","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.jep.2011.12.041","article-title":"Fighting fire with fire: poisonous Chinese herbal medicine for cancer therapy","volume":"140","author":"Wang","year":"2012","journal-title":"Ethnopharmacology"},{"issue":"36","key":"10.1016\/j.phrs.2021.105700_bib178","doi-asserted-by":"crossref","first-page":"7623","DOI":"10.1039\/C7OB01584D","article-title":"Developing antineoplastic agents that target peroxisomal enzymes: cytisine-linked isoflavonoids as inhibitors of hydroxysteroid 17-beta-dehydrogenase-4 (HSD17B4)","volume":"15","author":"Frasinyuk","year":"2017","journal-title":"Org. Biomol. Chem."},{"issue":"6","key":"10.1016\/j.phrs.2021.105700_bib179","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1248\/bpb.b20-00004","article-title":"Pharmacokinetics, tissue distribution, and druggability prediction of the natural anticancer active compound cytisine N-isoflavones combined with computer simulation","volume":"43","author":"Chen","year":"2020","journal-title":"Biol. Pharm. Bull."},{"issue":"9","key":"10.1016\/j.phrs.2021.105700_bib180","doi-asserted-by":"crossref","first-page":"1570","DOI":"10.1002\/cmdc.201500195","article-title":"Synthesis and antiplasmodial activity of novel chloroquine analogues with bulky basic side chains","volume":"10","author":"Tasso","year":"2015","journal-title":"ChemMedChem"},{"key":"10.1016\/j.phrs.2021.105700_bib181","doi-asserted-by":"crossref","DOI":"10.1016\/j.compbiolchem.2020.107407","article-title":"1,3-Oxazole derivatives of cytisine as potential inhibitors of glutathione reductase of Candida spp.: QSAR modeling, docking analysis and experimental study of new anti-Candida agents","volume":"90","author":"Metelytsia","year":"2021","journal-title":"Comput. Biol. Chem."},{"issue":"15","key":"10.1016\/j.phrs.2021.105700_bib182","doi-asserted-by":"crossref","first-page":"6273","DOI":"10.1021\/acs.joc.6b00804","article-title":"Dimeric matrine-type alkaloids from the roots of Sophora flavescens and their anti-hepatitis B virus activities","volume":"81","author":"Zhang","year":"2016","journal-title":"J. Org. Chem."},{"key":"10.1016\/j.phrs.2021.105700_bib183","first-page":"1","article-title":"Antiviral activity of amides and carboxamides of quinolizidine alkaloid (-)-cytisine against human influenza virus A (H1N1) and parainfluenza virus type 3","author":"Fedorova","year":"2019","journal-title":"Nat. Prod. Res."},{"issue":"10","key":"10.1016\/j.phrs.2021.105700_bib184","doi-asserted-by":"crossref","first-page":"2598","DOI":"10.1002\/ps.5375","article-title":"Semisynthesis of novel N-acyl\/sulfonyl derivatives of 5(3,5)-(di)halogenocytisines\/cytisine and their pesticidal activities against Mythimna separata Walker, Tetranychus cinnabarinus Boisduval, and Sitobion avenae Fabricius","volume":"75","author":"Huang","year":"2019","journal-title":"Pest Manag. Sci."}],"container-title":["Pharmacological Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S104366182100284X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S104366182100284X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T22:30:42Z","timestamp":1760913042000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S104366182100284X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,8]]},"references-count":184,"alternative-id":["S104366182100284X"],"URL":"https:\/\/doi.org\/10.1016\/j.phrs.2021.105700","relation":{},"ISSN":["1043-6618"],"issn-type":[{"value":"1043-6618","type":"print"}],"subject":[],"published":{"date-parts":[[2021,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cytisine and cytisine derivatives. More than smoking cessation aids","name":"articletitle","label":"Article Title"},{"value":"Pharmacological Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.phrs.2021.105700","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"105700"}}